GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

The radioactive drug industry is booming. The radiopharmaceuticals market is expected to grow 10% a year to reach more than ...

A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed ...

A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but more ...

Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.

We also report on a potential new use for another approved medicine that helped ​reduce suicidal thoughts in patients with ...

Nuclear medicine is being called a new frontier in cancer care, and new research shows potential new uses for it in treating gastric and pancreatic cancers. Nuclear medicine that uses radioactive ...

An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet ...

Merck (MRK.N), opens new tab said on Monday its experimental endometrial cancer drug met the main goals of a late-stage trial ...

Cancer care treatment at CARTI doesn’t just focus on the physical battle, but also the emotional challenges that come from ...